secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001683168-22-007393
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign Q3 2022 revenue $10.6M (+36% YoY); net income $0.85M; guides FY2022 rev $38.15-38.35M
--------------------------------------------------------------------------------

- Revenue $10.6M (+36% YoY); net income $0.85M vs loss of $0.27M in Q3 2021; diluted EPS $0.02.
- Adjusted EBITDA $1.9M ($0.04 per diluted share); gross margin improved to 54%.
- FY2022 revenue guidance $38.15M-$38.35M (29-30% growth); adjusted EBITDA expected $5.50-$5.60M.
- Added 13 plasma donation centers in Q3, ending with 450 centers; plasma revenue up 40% YoY.
- Unrestricted cash $8.0M; federal injunction allows Mexican nationals to donate plasma again.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316822007393/0001683168-22-007393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316822007393/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-007393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer